Literature DB >> 814483

Levodopa and psychometric test performance in parkinsonism-5 years later.

M Riklan, W Whelihan, T Cullinan.   

Abstract

Forty parkinsonian patients on levodopa therapy for a mean of 4 years and 10 months were given a battery of psychometric tests to assess memory cognition, and perception. Three equated control groups consisting of (1) parkinsonian patients not on levodopa, (2) patients on short-term levodopa, a mean of 1 year and 1 month, and (3) spouses, were administered a similar battery. The experimental group performed better than the nonlevodopa and the short-term groups on two subtests of intellectual functioning, but did less well on two tests of recent memory. All three parkinsonian groups consistently did significantly worse than spouses. When sex, age, and other relevant variables are equated, longer term levodopa therapy does not significantly after the overall pattern of psychometrically tested functions generally reported in parkinsonian patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 814483     DOI: 10.1212/wnl.26.2.173

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Relations between on-off phenomena and cognitive functions in Parkinson disease.

Authors:  G Meco; V Bonifati; L Bedini; A Bellatreccia; N Vanacore; A Franzese
Journal:  Ital J Neurol Sci       Date:  1991-02

2.  Cognitive performance and Parkinson disease: neuropsychological and CT study.

Authors:  D Pauletto; V Toso
Journal:  Ital J Neurol Sci       Date:  1987-04

3.  Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease.

Authors:  R G Brown; C D Marsden; N Quinn; M A Wyke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-05       Impact factor: 10.154

4.  A controlled study of dementia in Parkinson's disease.

Authors:  R H Mindham; S W Ahmed; C G Clough
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-11       Impact factor: 10.154

Review 5.  Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease.

Authors:  J Kulisevsky
Journal:  Drugs Aging       Date:  2000-05       Impact factor: 3.923

6.  Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

Authors:  B Pillon; B Dubois; G Cusimano; A M Bonnet; F Lhermitte; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

7.  Cognitive concomitants of dopamine system stimulation in parkinsonian patients.

Authors:  E Mohr; G Fabbrini; S Ruggieri; P Fedio; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.